Prevents persistently infected (PI) calves caused by bovine viral diarrhea (BVD) virus Types 1 and 2 and aids in preventing abortion caused by infectious bovine rhinotracheitis (IBR) virus and respiratory disease caused by IBR, BVD Types 1 and 2, and parainfluenza3 (PI3) virus; BVD Type 2 testicular infection; campylobacteriosis (vibriosis) caused by Campylobacter fetus and leptospirosis caused by the five Leptospira serovars. A 12-month duration of immunity (DOI) has been demonstrated against IBR induced abortion and persistently infected calves caused by BVD Types 1 and 2.
- Helps prevent BVD Types 1 and 2 persistent infections for at least 365 days.
- Aids in the prevention of IBR abortions for at least 365 days.
- Aids in the prevention of respiratory disease caused by IBR virus, BVD virus Types 1 and 2, and PI3 virus
- Aids in the prevention of campylobacteriosis caused by C. fetus and leptospirosis caused by the five serovars indicated above.
- Shown to be safe when given to pregnant cows or calves nursing pregnant cows.*
- Intramuscular (IM) dose is 2 mL, given to breeding cows and heifers approximately one month prior to breeding or being added to the herd, followed by a single dose of Vibrio/Leptoferm-5* two to four weeks later to help provide primary C. fetus and Leptospira immunization.
The Bovi-Shield GOLD® line and PregGuard GOLD FP 10 are recommended for vaccination of healthy cows and heifers approximately one month prior to breeding. These products also can be administered to pregnant cattle provided they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP or PregGuard GOLD FP vaccine prior to breeding initially and within 12 months thereafter. Failure to follow label directions may result in abortions. The Bovi-Shield GOLD line may be administered to calves nursing pregnant cows, provided their dams were vaccinated within the last 12 months, as described above. Consistent with good vaccination practices, heifers should receive at least two vaccine doses, with the second dose administered approximately 30 days prebreeding.
- General directions: Vaccination of healthy cattle is recommended. Aseptically rehydrate the freeze dried vaccine (PregGuard GOLD FP 10) with the liquid bacterin provided (Vibrio/Leptoferm-5®), shake well, and administer 2 mL intramuscularly. In accordance with Beef Quality Assurance guidelines, this product should be administered in the muscular region of the neck.
- Primary vaccination: Administer a single 2-mL dose to all breeding cows and heifers approximately one month prior to breeding or being added to the herd, followed two to four weeks later by a single dose of Vibrio/Leptoferm-5.
- Revaccination: Annual revaccination with a single dose of PregGuard GOLD FP 10 is recommended. Good animal husbandry and herd health management practices should be employed.
10- and 50-dose vials.
Precautions: Do not use in pregnant cows (abortions can result) unless they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP or PregGuard GOLD FP vaccine within the past 12 months. Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months as described above. Do not vaccinate calves under three months of age.
Consistent with good vaccination practices, it is recommended that heifers receive at least two doses, with the second dose administered approximately 30 days prebreeding.
- Store at 2°-7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency.
- Do not freeze.
- Use entire contents when first opened.
- Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine.
- Burn containers and all unused contents.
- Do not vaccinate within 21 days before slaughter.
- Contains Gentamicin as preservative.
- Vaccination of stressed animals should be delayed.
Occasional hypersensitivity reactions may occur up to 18 hours postvaccination. Owners should be advised to observe animals during this period. While this event appears to be rare overall, dairy cattle may be affected more frequently than cattle. Animals affected may display excessive salivation, incoordination, and/or dyspnea. Animals displaying such signs should be treated immediately with epinephrine or equivalent. In nonresponsive animals, other modes of treatment should be considered.
As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States